Invention Grant
- Patent Title: Osteoclast inhibitors such as zoledronic acid for low back pain treatment
-
Application No.: US15879107Application Date: 2018-01-24
-
Publication No.: US10092581B2Publication Date: 2018-10-09
- Inventor: Herriot Tabuteau , Jaro I. Karppinen
- Applicant: ANTECIP BIOVENTURES II LLC
- Applicant Address: US NY New York
- Assignee: ANTECIP BIOVENTURES II LLC
- Current Assignee: ANTECIP BIOVENTURES II LLC
- Current Assignee Address: US NY New York
- Agency: Maschoff Brennan Laycock Gilmore Israelsen & Wrigh
- Agent Brent A. Johnson; Yuefen Zhou
- Main IPC: A61K31/66
- IPC: A61K31/66 ; A61K31/675 ; A61K9/20 ; A61K9/00 ; A61K31/663
Abstract:
Oral dosage forms of osteoclast inhibitors, such as zoledronic acid, in an acid or a salt form can be used to treat or alleviate pain or related conditions, such as Modic changes type 1.
Public/Granted literature
- US20180161348A1 OSTEOCLAST INHIBITORS SUCH AS ZOLEDRONIC ACID FOR LOW BACK PAIN TREATMENT Public/Granted day:2018-06-14
Information query
